Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy

Abstract

Although wild-type failure during early integrase inhibitor failure is common, most patients eventually develop high-level phenotypic drug resistance. This resistance evolution is gradual and associated with declines in replicative capacity.